Lv1
60 积分 2025-08-28 加入
Oral Muvalaplin for Lowering of Lipoprotein(a)
14小时前
已完结
Therapeutic lowering of lipoprotein(a): implications for improving outcomes in patients with peripheral arterial disease
1天前
已完结
The Role of Antisense Therapies Targeting Lipoprotein(a)
1天前
已完结
Lipoprotein(a): A Review of Risk Factors, Measurements, and Novel Treatment Modalities
1天前
已完结
Management of dyslipidemia in coronary artery disease: the present and the future
1天前
已完结
Early health technology assessment of gene silencing therapies for lowering lipoprotein(a) in the secondary prevention of coronary heart disease
1天前
已完结
Oral agents for lowering lipoprotein(a)
1天前
已完结
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)
1天前
已完结
Lipid Abnormalities and Cardiovascular Risk in Renal Disease
15天前
已完结
Dyslipidemia and Diabetic Macular Edema
15天前
已完结
皖公网安备34019202002308
